Tnloh4jr24uyu4uli3sjxjq3

.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
Ref By : SELF Gender : Male
Collected : 18/5/2024 3:30:00PM Reported : 19/5/2024 5:50:29AM
A/c Status : P Report Status : Final
Collected at : KAITHAL-CC5 Processed at : Dr. Lal PathLabs Ltd.
Janakpuri Colony,1,HARSH HOTAL,Opp Civil Secretariat-Huda Road,
Hospital, Kaithal-136027,Haryana
KAITHAL,
KAITHAL136027
HRY ,IND Opp Civil Hospital, KAITHAL mb
9034678005
KAITHAL 136027
Test Report
Test Name Results Units Bio. Ref. Interval
SwasthFit Super 4
LIVER & KIDNEY PANEL, SERUM

(Reflectance Photometry,Indirect ISE)
Creatinine 0.57 mg/dL 0.62 - 1.17
GFR Estimated 127 mL/min/1.73m2 >59
GFR Category G1
Urea 28.63 mg/dL 13.00 - 43.00
Urea Nitrogen Blood 13.37 mg/dL 6.00 - 20.00
BUN/Creatinine Ratio 23
Uric Acid 6.07 mg/dL 3.50 - 7.20
AST (SGOT) 20.8 U/L 15.00 - 40.00
ALT (SGPT) 20.9 U/L <49.00
GGTP 31.5 U/L 10.00 - 45.00
Alkaline Phosphatase (ALP) 111.14 U/L 40.00 - 129.00
Bilirubin Total 0.57 mg/dL 0.30 - 1.20
Bilirubin Direct 0.10 mg/dL 0.00 - 0.40
Bilirubin Indirect 0.47 mg/dL <1.10
Total Protein 6.48 g/dL 6.00 - 8.00
Albumin 3.90 g/dL 3.50 - 5.20
A : G Ratio 1.51 0.90 - 2.00
*175658822* Page 1 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report

Globulin(Calculated) 2.58 gm/dL 2.0 - 3.5
Calcium, Total 8.82 mg/dL 8.80 - 10.20
Phosphorus 3.80 mg/dL 2.50 - 4.50
Sodium 141.40 mEq/L 135.00 - 148.00
Potassium 4.11 mEq/L 3.50 - 5.30
Chloride 103.20 mEq/L 98.00 - 107.00
*175658822* Page 2 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report
LIPID SCREEN, SERUM

(CHOD-POD)
Cholesterol, Total 210.92 mg/dL <200.00
Triglycerides 281.63 mg/dL <150.00
HDL Cholesterol 32.42 mg/dL >40.00
LDL Cholesterol, Calculated 122.17 mg/dL <100.00
VLDL Cholesterol,Calculated 56.33 mg/dL <30.00
Non-HDL Cholesterol 179 mg/dL <130
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.
Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category B | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months
*175658822* Page 3 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report
GLUCOSE, FASTING (F)

(Hexokinase)
Glucose Fasting Sample Not Received

SNR01-
VITAMIN B12; CYANOCOBALAMIN

(ECLIA)
Vitamin B12; Cyanocobalamin 126.00 pg/mL 211.00 - 946.00
Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific
3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients
4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity
VITAMIN D, 25 - HYDROXY, SERUM

(ECLIA)
Vitamin D, 25 Hydroxy 86.93 nmol/L 75.00 - 250.00
Interpretation
------------------------------------------------------------------------------------------------
| LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS |
|---------------|--------------------------|-----------------------------------------------------|
| Deficient | < 50 | High risk for developing bone disease |
|---------------|--------------------------|-----------------------------------------------------|
| Insufficient | 50-74 | Vitamin D concentration which normalizes |
| | | Parathyroid hormone concentration |
|---------------|--------------------------|-----------------------------------------------------|
| Sufficient | 75-250 | Optimal concentration for maximal health benefit |
*175658822* Page 4 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report

|---------------|--------------------------|-----------------------------------------------------|
| Potential | >250 | High risk for toxic effects |
| intoxication | | |
------------------------------------------------------------------------------------------------
Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available
THYROID PROFILE,TOTAL, SERUM

(ECLIA)
T3, Total 1.38 ng/mL 0.80 - 2.00
T4, Total 7.01 µg/dL 5.10 - 14.10
TSH 3.67 µIU/mL 0.27 - 4.20
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
*175658822* Page 5 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)
HbA1c 5.5 % 4.00 - 5.60
Estimated average glucose (eAG) 111 mg/dL
Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines
------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------
*175658822* Page 6 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report
COMPLETE BLOOD COUNT; CBC

(Spectrophotometry, Electrical Impedance, Analogical Integration, Calculated & Manual Microscopy)
Hemoglobin 12.30 g/dL 13.00 - 17.00
Packed Cell Volume (PCV) 39.70 % 40.00 - 50.00
RBC Count 4.71 mill/mm3 4.50 - 5.50
MCV 84.00 fL 83.00 - 101.00
MCH 26.20 pg 27.00 - 32.00
MCHC 31.10 g/dL 31.50 - 34.50
Red Cell Distribution Width (RDW) 16.20 % 11.60 - 14.00
Total Leukocyte Count (TLC) 5.30 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 52.50 % 40.00 - 80.00
Lymphocytes 40.10 % 20.00 - 40.00
Monocytes 5.40 % 2.00 - 10.00
Eosinophils 2.00 % 1.00 - 6.00
Basophils 0.00 % <2.00
Absolute Leucocyte Count
Neutrophils 2.78 thou/mm3 2.00 - 7.00
Lymphocytes 2.13 thou/mm3 1.00 - 3.00
Monocytes 0.29 thou/mm3 0.20 - 1.00
Eosinophils 0.11 thou/mm3 0.02 - 0.50
Basophils 0.00 thou/mm3 0.02 - 0.10
Platelet Count 202 thou/mm3 150.00 - 410.00
Mean Platelet Volume 10.0 fL 6.5 - 12.0
Note
*175658822* Page 7 of 8
.
Name : Mr. SHYAMLAL

Lab No. : 175658822 Age : 40 Years
KAITHAL,
KAITHAL136027
9034678005
KAITHAL 136027
Test Report
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
Dr Garima Gupta
MD, Pathology
Chief of Laboratory
Dr Lal PathLabs Ltd
-------------------------------End of report --------------------------------

AHEEEHAPMKHIBPDNLKAHANNCBILLJCECCJICIKPKNKEDFFFAPPAHEEEHA
BNFFFNBPAPBKFHAGFGEOJGIPAOAHFHAKAKJOBCJONLEKMGJGMPBNFFFNB
CIEGCHFPNMOEKFBOPFIAAJHFJEHEHEDFJKPHENFLMLKIOEFLBLHDEHANP
DJHKKGFNBMEIEDILBKMELFMFANHLALBFJIFFPBPAKCLJPDNLILNBKEMEK
KBMDLHFJOBJFDIAENNGCKPJHJENJONCHKKMFAKEIPLKGKPNGKFFFOOOMD
PMCBBEFMMICGDLHKIPMHKIPBADHFOFAINCECBKDKALIKOMNALNEJPGMCD
LHIMIJFJELOFNFCIEKMNCFEHIHAFJBALOHMPBLMGOJCHKJNBAJNJIDILD
NJJJAMFNALOOAEDJGANHDJDILKBMFMBDMFCCAMNNIIKNOPNCBNFNBHILL
NKCBNDFPEPIGFAAIIOMIHIIKHGEFEKFBJFFLALPFOOBIOCNKDJPHNEKLJ
NPDOONFCELJJJDCJEEBFGPNGKDFKPNJHKEPHENFLNKCKIGEOCJLKHIANP
AGIKOLFLGKCBMNDMPJFCEJEEINMPNAABJNFEBFOEONDMKPFKEPCIGCIEG
IGICGJFCPLDLEPBMHHGAHOAEIEOPPFOFBONPBLNOOLJBIKNJNKONHDICL
MNNNNNEHCFDIHKGJOCFLHLJHJBAHFHAHJKPFCMNLMKJCLFNNAHFHAHIKL
APBBBPAPBOGAEJBJHNCKCBKFAHFCHHCAONFEPKPGOLMHNLNFEDFCHBKHH
HHHHHHHPHPHPHPPPPPPPPPHHHHPPPPPPPPPPHHPPPHHHPHPHHHHHHHPHP
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
*175658822* Page 8 of 8

Tnloh4jr24uyu4uli3sjxjq3

Uploaded by

Copyright:

Available Formats

Tnloh4jr24uyu4uli3sjxjq3

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Tnloh4jr24uyu4uli3sjxjq3

Uploaded by

Copyright:

Available Formats

.

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

LIVER & KIDNEY PANEL, SERUM

Creatinine 0.57 mg/dL 0.62 - 1.17

GFR Estimated 127 mL/min/1.73m2 >59

Urea 28.63 mg/dL 13.00 - 43.00

Urea Nitrogen Blood 13.37 mg/dL 6.00 - 20.00

Uric Acid 6.07 mg/dL 3.50 - 7.20

AST (SGOT) 20.8 U/L 15.00 - 40.00

ALT (SGPT) 20.9 U/L <49.00

GGTP 31.5 U/L 10.00 - 45.00

Alkaline Phosphatase (ALP) 111.14 U/L 40.00 - 129.00

Bilirubin Total 0.57 mg/dL 0.30 - 1.20

Bilirubin Direct 0.10 mg/dL 0.00 - 0.40

Bilirubin Indirect 0.47 mg/dL <1.10

Total Protein 6.48 g/dL 6.00 - 8.00

Albumin 3.90 g/dL 3.50 - 5.20

A : G Ratio 1.51 0.90 - 2.00

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

Calcium, Total 8.82 mg/dL 8.80 - 10.20

Phosphorus 3.80 mg/dL 2.50 - 4.50

Sodium 141.40 mEq/L 135.00 - 148.00

Potassium 4.11 mEq/L 3.50 - 5.30

Chloride 103.20 mEq/L 98.00 - 107.00

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

LIPID SCREEN, SERUM

Cholesterol, Total 210.92 mg/dL <200.00

Triglycerides 281.63 mg/dL <150.00

HDL Cholesterol 32.42 mg/dL >40.00

LDL Cholesterol, Calculated 122.17 mg/dL <100.00

VLDL Cholesterol,Calculated 56.33 mg/dL <30.00

Non-HDL Cholesterol 179 mg/dL <130

Treatment Goals as per Lipid Association of India 2020

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F)

Glucose Fasting Sample Not Received

VITAMIN B12; CYANOCOBALAMIN

Vitamin B12; Cyanocobalamin 126.00 pg/mL 211.00 - 946.00

VITAMIN D, 25 - HYDROXY, SERUM

Vitamin D, 25 Hydroxy 86.93 nmol/L 75.00 - 250.00

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

THYROID PROFILE,TOTAL, SERUM

T3, Total 1.38 ng/mL 0.80 - 2.00

T4, Total 7.01 µg/dL 5.10 - 14.10

TSH 3.67 µIU/mL 0.27 - 4.20

Name : Mr. SHYAMLAL

Test Name Results Units Bio. Ref. Interval

HbA1c 5.5 % 4.00 - 5.60

Estimated average glucose (eAG) 111 mg/dL

Name : Mr. SHYAMLAL

COMPLETE BLOOD COUNT; CBC

Hemoglobin 12.30 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 39.70 % 40.00 - 50.00

RBC Count 4.71 mill/mm3 4.50 - 5.50